Pharmaceutical company Eli Lilly began to search for ways to boost serotonin in the brain without affecting other neurotransmitters. In 1974, they were successful, publishing a report on their first selective serotonin reuptake inhibitor (SSRI): fluoxetine. By 1988, fluoxetine had been approved by the FDA and released under the trade name Prozac®.
